Cargando…

TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway

BACKGROUND: Esophageal carcinoma is the eighth prevalent malignancy and ranks the sixth in carcinoma-related death worldwide. Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) has been identified as a tumor suppressor in multiple carcinomas. However, its roles and molecular mechanisms underly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linan, Zhang, Xudong, Fu, Xiaorui, Li, Zhaoming, Sun, Zhenchang, Wu, Jingjing, Wang, Xinhua, Wang, Feng, Li, Xiangke, Niu, Songtao, Ding, Mengjie, Yang, Zhenzhen, Yang, Wanqiu, Yin, Meifeng, Zhang, Lei, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773041/
https://www.ncbi.nlm.nih.gov/pubmed/29343267
http://dx.doi.org/10.1186/s12967-018-1383-0
_version_ 1783293496930598912
author Zhu, Linan
Zhang, Xudong
Fu, Xiaorui
Li, Zhaoming
Sun, Zhenchang
Wu, Jingjing
Wang, Xinhua
Wang, Feng
Li, Xiangke
Niu, Songtao
Ding, Mengjie
Yang, Zhenzhen
Yang, Wanqiu
Yin, Meifeng
Zhang, Lei
Zhang, Mingzhi
author_facet Zhu, Linan
Zhang, Xudong
Fu, Xiaorui
Li, Zhaoming
Sun, Zhenchang
Wu, Jingjing
Wang, Xinhua
Wang, Feng
Li, Xiangke
Niu, Songtao
Ding, Mengjie
Yang, Zhenzhen
Yang, Wanqiu
Yin, Meifeng
Zhang, Lei
Zhang, Mingzhi
author_sort Zhu, Linan
collection PubMed
description BACKGROUND: Esophageal carcinoma is the eighth prevalent malignancy and ranks the sixth in carcinoma-related death worldwide. Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) has been identified as a tumor suppressor in multiple carcinomas. However, its roles and molecular mechanisms underlying esophageal carcinoma progression are still undefined till now. METHODS: RT-qPCR assay was employed to detect the expression of TIPE2 mRNA. TIPE2 protein expression was measured by using western blot assay. Ad-V and Ad-TIPE2 adenoviruses were constructed to overexpress TIPE2. The effects of TIPE2 overexpression on cell proliferation, invasion and apoptosis were assessed by MTT and Edu incorporation assays, transwell invasion assay and flow cytometry analysis, respectively. The effect of TIPE2 overexpression on xenograft tumor growth was determined by measuring tumor volume and weight, together with immunohistochemistry assay. The effect of TIPE2 overexpression on the Wnt/β-catenin signaling pathway was evaluated by detecting the protein levels of β-catenin, c-Myc and cyclinD1 in EC9076 cells and xenograft tumors of esophageal carcinoma. RESULTS: TIPE2 expression was downregulated in esophageal carcinoma tissues and cells. Adenovirus-mediated TIPE2 overexpression suppressed cell proliferation and invasion, and induced apoptosis in esophageal carcinoma cells. Enforced expression of TIPE2 inhibited tumor growth in vivo, as evidenced by the reduced tumor volume, tumor weight and proliferating cell nuclear antigen expression. Overexpression of TIPE2 inhibited the Wnt/β-catenin signaling pathway in esophageal carcinoma in vitro and in vivo. CONCLUSIONS: These results suggest that TIPE2 suppressed progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
format Online
Article
Text
id pubmed-5773041
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57730412018-01-26 TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway Zhu, Linan Zhang, Xudong Fu, Xiaorui Li, Zhaoming Sun, Zhenchang Wu, Jingjing Wang, Xinhua Wang, Feng Li, Xiangke Niu, Songtao Ding, Mengjie Yang, Zhenzhen Yang, Wanqiu Yin, Meifeng Zhang, Lei Zhang, Mingzhi J Transl Med Research BACKGROUND: Esophageal carcinoma is the eighth prevalent malignancy and ranks the sixth in carcinoma-related death worldwide. Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) has been identified as a tumor suppressor in multiple carcinomas. However, its roles and molecular mechanisms underlying esophageal carcinoma progression are still undefined till now. METHODS: RT-qPCR assay was employed to detect the expression of TIPE2 mRNA. TIPE2 protein expression was measured by using western blot assay. Ad-V and Ad-TIPE2 adenoviruses were constructed to overexpress TIPE2. The effects of TIPE2 overexpression on cell proliferation, invasion and apoptosis were assessed by MTT and Edu incorporation assays, transwell invasion assay and flow cytometry analysis, respectively. The effect of TIPE2 overexpression on xenograft tumor growth was determined by measuring tumor volume and weight, together with immunohistochemistry assay. The effect of TIPE2 overexpression on the Wnt/β-catenin signaling pathway was evaluated by detecting the protein levels of β-catenin, c-Myc and cyclinD1 in EC9076 cells and xenograft tumors of esophageal carcinoma. RESULTS: TIPE2 expression was downregulated in esophageal carcinoma tissues and cells. Adenovirus-mediated TIPE2 overexpression suppressed cell proliferation and invasion, and induced apoptosis in esophageal carcinoma cells. Enforced expression of TIPE2 inhibited tumor growth in vivo, as evidenced by the reduced tumor volume, tumor weight and proliferating cell nuclear antigen expression. Overexpression of TIPE2 inhibited the Wnt/β-catenin signaling pathway in esophageal carcinoma in vitro and in vivo. CONCLUSIONS: These results suggest that TIPE2 suppressed progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway. BioMed Central 2018-01-17 /pmc/articles/PMC5773041/ /pubmed/29343267 http://dx.doi.org/10.1186/s12967-018-1383-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhu, Linan
Zhang, Xudong
Fu, Xiaorui
Li, Zhaoming
Sun, Zhenchang
Wu, Jingjing
Wang, Xinhua
Wang, Feng
Li, Xiangke
Niu, Songtao
Ding, Mengjie
Yang, Zhenzhen
Yang, Wanqiu
Yin, Meifeng
Zhang, Lei
Zhang, Mingzhi
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
title TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
title_full TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
title_fullStr TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
title_full_unstemmed TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
title_short TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
title_sort tipe2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the wnt/β-catenin pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773041/
https://www.ncbi.nlm.nih.gov/pubmed/29343267
http://dx.doi.org/10.1186/s12967-018-1383-0
work_keys_str_mv AT zhulinan tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT zhangxudong tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT fuxiaorui tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT lizhaoming tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT sunzhenchang tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT wujingjing tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT wangxinhua tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT wangfeng tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT lixiangke tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT niusongtao tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT dingmengjie tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT yangzhenzhen tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT yangwanqiu tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT yinmeifeng tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT zhanglei tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway
AT zhangmingzhi tipe2suppressesprogressionandtumorigenesisofesophagealcarcinomaviainhibitionofthewntbcateninpathway